No Data
No Data
Alpha Tau Granted FDA Approval To Initiate Trial For Patients With Recurrent Glioblastoma
Express News | Alpha Tau Receives FDA Approval to Initiate a Trial for Patients With Recurrent Glioblastoma
Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $8
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Alpha Tau Medical Analyst Ratings
包菜好健康 : sir, what do you think about FUBO?
This_Guy OP 包菜好健康 : I have only day traded it based on charts and a catalyst. It's not a stock I would hold right now and I do not know enough about the company to make suggestions, sorry.